|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used by operations | |||||
| Depreciation and amortization | |||||
| Amortization of stock issued for services | |||||
| Debt discount amortization | |||||
| Stock issued for services | |||||
| Purchase of software and equipment | |||||
| Depreciation and amortization - cost of goods sold | |||||
| Depreciation and amortization - operations | |||||
| Bad debt reserve | |||||
| Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | |||||
| Accounts receivable, net - unbilled | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Total Adjustments to reconcile Net loss to Net Cash used in operations | |||||
| Total Adjustments | |||||
| Accounts receivable | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Cost incurred to develop intellectual property | |||||
| Costs incurred to develop intellectual property | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from sale of shares for cash | |||||
| Shares issued for cash | |||||
| Proceeds from related party loan | |||||
| Repayment of related party loan | |||||
| Proceeds from notes payable, net | |||||
| Net cash (used in) provided by financing activities | |||||
| Net cash (decrease) increase for the year | |||||
| Cash at beginning of year | |||||
| Cash at end of year | |||||
| Supplemental disclosures: | |||||
| Shares issued for consulting recorded as prepaid, net | |||||
| Common Stock issued in exchange for services | |||||
| Shares issued in settlement | |||||
Loading...